Valuation: Genesis Fertility Center

Market Cap 475M 14.42M 12.47M 11.64M 10.68M 20.09M 1.37B 20.41M 137M 53.62M 688M 54.13M 52.95M 2.27B P/E 2026 *
30.9x
P/E 2027 * 27x
Enterprise Value 475M 14.42M 12.47M 11.64M 10.68M 20.09M 1.37B 20.41M 137M 53.62M 688M 54.13M 52.95M 2.27B EV / Sales 2026 *
1.37x
EV / Sales 2027 * 1.29x
Free-Float
17.02%
Yield 2026 *
2.31%
Yield 2027 * 2.31%
05-14 Genesis Fertility Center Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-14 Genesis Fertility Center Public Company Limited Announces Board and Committee Changes CI
02-23 Genesis Fertility Center Public Company Limited Proposes Cash Dividend for the Year Ended 31 December 2025, Payable on 26 May 2026 CI
02-23 Genesis Fertility Center Public Company Limited Announces Changes in Committee Compositions, Effective February 23, 2026 CI
02-23 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
12-17 Genesis Fertility Center Public Company Limited Announces Board and Committee Resignations, Effective December 16, 2025 CI
11-10 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-09-16 Genesis Fertility Center appoints Nathee Tungchitsodsai as CEO RE
25-09-15 Genesis Fertility Center Public Company Limited Announces Appointment of Nathee Tungchitsodsai as Chief Executive Officer, Effective 16 October 2025 CI
25-09-12 90,750,000 Common Shares of Genesis Fertility Center Public Company Limited are subject to a Lock-Up Agreement Ending on 13-SEP-2025. CI
25-08-15 Genesis Fertility Center Public Company Limited Announces Executive Changes CI
25-08-13 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-08-12 Genesis Fertility Center Public Company Limited Announces Cash Dividend for the Period from January 1, 2025 to June 30, 2025, Payable on September 10, 2025 CI
1 day-0.92%
1 week-4.42%
Current month-4.42%
1 month-6.90%
3 months-22.30%
6 months-22.30%
Current year-28.00%
1 week 2.12
Extreme 2.12
2.28
1 month 2.12
Extreme 2.12
2.38
Current year 2.12
Extreme 2.12
3.18
1 year 2.12
Extreme 2.12
4.18
3 years 2.12
Extreme 2.12
13.3
5 years 2.12
Extreme 2.12
13.3
10 years 2.12
Extreme 2.12
13.3
Manager TitleAgeSince
Chief Executive Officer - 2025-10-15
Director of Finance/CFO 48 2019-12-31
Chief Operating Officer 43 2016-12-07
Director TitleAgeSince
Chairman 57 2016-12-07
Director/Board Member 53 2021-11-15
Director/Board Member 57 2016-12-07
Date Insider Type Main position Quantity % Market Cap.
12/2/24 Others

Director

1,400,000 0.6364%
11/29/24 Buy

Founder

9,400 0.0043%
11/27/24 Others

Director

1,400,000 0.6364%
Change 5-day change 1-year change 3-year change Capi.($)
-0.92%-4.42%-48.08% - 14.55M
-0.29%-9.38%+47.18%+29.11% 122B
+0.28%+2.17%+8.49%+54.98% 89.49B
+0.07%+5.18%+7.51%+57.70% 30.64B
-0.63%+2.11%+32.79%+76.59% 26.31B
+0.13%-0.81%-11.89%-13.98% 21.65B
-0.21%+4.99%+57.51%+255.31% 21.11B
+0.65%-5.73%+2.00%-11.77% 12.88B
-1.00%-22.11%+41.04%+67.86% 11.72B
-0.28%-2.60%-14.02%+94.63% 10.97B
Average -0.22%-3.22%+12.25%+67.83% 34.72B
Weighted average by Cap. -0.09%-2.53%+25.74%+54.83%

Financials

2026 *2027 *
Net sales 346M 10.5M 9.08M 8.48M 7.78M 14.63M 999M 14.86M 99.47M 39.04M 501M 39.41M 38.55M 1.66B 368M 11.16M 9.66M 9.02M 8.27M 15.56M 1.06B 15.81M 106M 41.53M 533M 41.92M 41M 1.76B
Net income 15M 455K 394K 368K 337K 634K 43.31M 644K 4.31M 1.69M 21.71M 1.71M 1.67M 71.76M 17M 516K 446K 417K 382K 719K 49.08M 730K 4.89M 1.92M 24.6M 1.94M 1.89M 81.33M
Net Debt - -
Logo Genesis Fertility Center
Genesis Fertility Center PCL is a Thailand-based company engaged in the healthcare sector, primarily providing fertility and reproductive healthcare services. The Company provides treatment and counseling services to infertile people, chromosome analysis by NGS technique services and provide investment services in other businesses, consulting and management services. The Company provides assisted reproductive technology services, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI) and Intrauterine Insemination (IUI). Its service offerings also include Frozen Embryo Transfer (FET), egg freezing services and Preimplantation Genetic Testing for Aneuploidy (PGT-A) using laboratory-based screening methods. The Company serves both domestic and international patients through its network of fertility clinics and healthcare facilities. The Company operates through its subsidiaries such as Genosomics Company Limited, GFC Fertility Group Company Limited, and others.
Employees
-
Date Price Change Volume
26-08-09 THB 2.160 -0.92% 262,701
26-08-07 THB 2.180 -2.68% 682,900
26-08-06 THB 2.240 -0.88% 15,900
26-08-05 THB 2.260 -0.88% 24,200
26-08-04 THB 2.280 0.00% 42,518

Quarterly revenue - Rate of surprise